Peter Staib
Sankt-Antonius-Hospital Eschweiler(DE)Association of Clinical Pathologists(GB)Oncology Specialists(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Antifungal resistance and susceptibility, Chronic Myeloid Leukemia Treatments, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial(2010)1,860 cited
- → Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease(2002)963 cited
- → Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group(2012)431 cited
- → Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group(2011)372 cited
- → Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group(2008)337 cited